|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4 Suppl 34
|
|
pubmed:dateCreated |
2004-11-1
|
|
pubmed:abstractText |
About a quarter of familial Mediterranean fever (FMF) patients are partially or totally resistant to colchicine. A previous observation reported that acute attacks may be shortened by administration of interferon alpha (IFN).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0392-856X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
S37-40
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15515782-Acute Disease,
pubmed-meshheading:15515782-Adult,
pubmed-meshheading:15515782-C-Reactive Protein,
pubmed-meshheading:15515782-Double-Blind Method,
pubmed-meshheading:15515782-Familial Mediterranean Fever,
pubmed-meshheading:15515782-Female,
pubmed-meshheading:15515782-Humans,
pubmed-meshheading:15515782-Immunologic Factors,
pubmed-meshheading:15515782-Interferon-alpha,
pubmed-meshheading:15515782-Male,
pubmed-meshheading:15515782-Placebos,
pubmed-meshheading:15515782-Serum Amyloid A Protein,
pubmed-meshheading:15515782-Treatment Outcome
|
|
pubmed:articleTitle |
The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: A double-blind, placebo-controlled trial.
|
|
pubmed:affiliation |
Dokuz Eylül University School of Medicine, Department of Internal Medicine, Izmir, Turkey. tunca@superonline.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
